Posts

sstar-ceo-nancy-e-paull-builds-addiction-research-facility

SSTAR Opens Research Facility

sstar-ceo-nancy-e-paull

SSTAR CEO, Nancy Paull

SSTAR, a substance-abuse treatment organization, is formulating plans for an addiction treatment research facility in Fall River, MA. “It will be a small part of a full treatment center,” said CEO Nancy E. Paull. “I’m not building a methadone clinic. I’m building a research and treatment facility.” According to The Herald News, this facility will be complete with inpatient treatment, outpatient clinical services, and will perform research into programs and therapies. One possible location is the former home of Border City Mill No. 3 intersecting Weaver and West streets. This building was lost in a fire of February of this year.

Plans call for a research facility with 60 beds (30 of which are for individuals) in their detox program with 30 more servicing those in need of rehabilitation. Furthermore, this will be supplemented with an outpatient medication-assisted treatment program. “We’ll expand our treatment services,” Paull said. “It will allow us to expand our research. It will allow us to increase primary care.”

For 40 years, SSTAR has dedicated themselves to providing a range of mental health and substance abuse treatment services. Because of this, they recognize the extent of the opioid crisis and the tremendous need for their services in Fall River. Yet, they’re only capable of handling 20% of those in need of in-patient treatment. “There is a huge demand for services that we are not able to meet,” Paull said. No official sale was made, but a decision is expected within the next 30 to 60 days.

About SSTAR

Stanley Street Treatment and Resources (SSTAR) is a non-profit health care and social service agency. They serve Southeastern Massachusetts communities with a wide-range of mental health and substance abuse treatment services. SSTAR programs are licensed by the Massachusetts Department of Public Health and the Department of Mental Health Retardation.

Learn more

sstar-prevention-services

Addiction Prevention Services in Taunton

SSTAR Expands Prevention Services

sstar-prevention-services

Fall 2016, Taunton, MA based addiction treatment center SSTAR will soon open a new facility. This location will provide prevention services and resources such as awareness events, physician training, and other educational efforts.  This undertaking was spurred by the growing demand for these services at their other locations.

SSTAR Program Director Laura Washington and Task Force member Kiara Zea are leading this new effort. The City of  Tauton has long been a champion in the fight against addiction. As Director Washington affirmed, “This municipality is very progressive and on the forefront of this epidemic…” In 2012, the state of Massachusetts declared opioid addiction a public health crisis. Since then, numbers have been on a steady increase. However, without the treatment, prevention and awareness measures taken since then, the numbers would certainly be even higher still.

Narcan Helps, But Only So Much

Lives are being saved everyday by the overdose reversing drug Narcan. For the past 3 year fire fighters in Taunton have been trained to administer Narcan. Unfortunately,  “Some of the fatal deaths in town have been people that were revived with Narcan before, successfully, and then they ended up OD’ing,” according to Tim Bradshaw, chief of the Taunton Fire Department. This is the very nature of addiction.

This is why multiple approaches are so important. Approaches like SSTAR’s efforts toward increasing prevention services in addition to addiction treatment and recovery services help to make help available to people no matter where they are in their journey towards recovery.

About SSTAR

Established in 1977, SSTAR is a non-profit Massachusetts-based licensed health care and social services agency. They provide mental health and substance use treatment services to residents of Tauton. Their mission is to provide quality care and support services to individuals struggling with mental health and substance use disorders.

http://taunton.wickedlocal.com/news/20161003/sstar-prevention-services-opens-taunton-office-to-help-in-drug-abuse-prevention-efforts

http://easton.wickedlocal.com/opinion/20160516/our-view-greater-taunton-is-rising-to-fight-addiction

http://www.abc6.com/story/30486823/taunton-a-community-look-at-the-heroin-epidemic

sstar-location

SSTAR Investigates Injectable Buprenorphine

SSTA- Investigates-Injectable-BuprenorphineIn addition to being a trusted addiction treatment services provider, Fall River-based Stanley Street Treatment and Resources Inc. ( SSTAR ) has been engaging in addiction research projects for many years, and is now helping to vet the next generation of medication-assisted treatment (MAT). SSTAR is currently investigating the safety and efficacy of injectable buprenorphine. This medication could potentially eliminate the need for daily visits to the clinic to receive doses. Patients who are eligible to participate in this pharmaceutical study will receive free buprenorphine treatment for up to 6 months and individualized weekly counseling. SSTARS Dr. Baily pointed out in a recent article that, “Access to cutting edge care through research is especially important to the uninsured and underinsured population by making access to treatment and medication easier and available at little to no cost to participants.”

Since 2002, Buprenorphine has been approved for the treatment of pain and opioid addiction in the form of tablets and film. According to the Substance Abuse and Mental Health Services Administration (SAMHSA) the properties of buprenorphine help to:

  • Lower the potential for misuse
  • Diminish the effects of physical dependency to opioids, such as withdrawal symptoms and cravings
  • Increase safety in cases of overdose

One manufacturer, Braeburn Pharmaceuticals and Camurus recently entered into the Phase 2 of their study of CAM2038, weekly and monthly subcutaneous buprenorphine injections. Behshad Sheldon, President and CEO, Braeburn Pharmaceuticals said, “Our goal is to provide a suite of best-in-class, long-acting treatment options tailored to the individual needs of patients suffering from opioid dependence and chronic pain.”

Read more in the article by Dr. Genie Bailey of SSTAR